At Charles River, we can appreciate how complex your inflammatory disease research can be. We have the experience and expertise to help advance your understanding of the cellular processes involved and identify therapeutic targets and markers of disease to develop new approaches for diagnosis, prevention and treatment.
Inflammation is a natural biological response to irritation or injury that promotes healing and repair. However, inappropriately triggered or incompletely controlled inflammatory responses are a major cause of ill health, impaired quality of life and morbidity. Our research models, discovery services, preclinical pharmacology models, safety assessment programs and full laboratory support services enable us to expertly and efficiently support your research in the area of inflammation.
Related Information
Webinar Replay - Markers of Inflammation (June 2011)
Webinar Replay - Preclinical Pulmonary Inflammation Models (October 2010)
Webinar Replay - Inflammation Models in Preclinical Drug Research: Traditional Endpoints to Translational Imaging (September 2010)